Pharmaceutical companies, fearful of running afoul of the U.S. Food and Drug Administration’s marketing guidelines, have virtually abandoned search ad marketing in the wake of the FDA’s online ad crackdown earlier this year. According to a study from web metrics measurement firm ComScore, paid search ads by pharmaceutical companies dropped a whopping 84% between March 26 of this year and the end of June.